Related references
Note: Only part of the references are listed.Is Therapeutic Drug Monitoring of Lacosamide Needed in Patients with Seizures and Epilepsy?
Lynnea Schultz et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2020)
Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial
David G. Vossler et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Treatment with topiramate and lacosamide during status epilepticus attenuates motor seizure and oxidative stress in rats
M. Shishmanova-Doseva et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Lacosamide Pharmacokinetics in a Critically Ill Patient During Continuous Renal Replacement Therapy
Patrick M. Wieruszewski et al.
JOURNAL OF PHARMACY PRACTICE (2020)
Dysregulation of CRMP2 Post-Translational Modifications Drive Its Pathological Functions
Aubin Moutal et al.
MOLECULAR NEUROBIOLOGY (2019)
The Impact of Prophylactic Lacosamide on LPS-Induced Neuroinflammation in Aged Rats
Mehtap Savran et al.
INFLAMMATION (2019)
Modeling and simulation for the evaluation of dose adaptation rules of intravenous lacosamide in children
Julia Winkler et al.
EPILEPSY RESEARCH (2019)
Lacosamide Pharmacokinetics in a Critically Ill Patient Receiving Continuous Venovenous Hemofiltration
Miguel J. Franquiz et al.
PHARMACOTHERAPY (2018)
Lacosamide efficacy and tolerability in clinical practice - Post marketing analysis from a single dedicated epilepsy center
Mark D. Baker et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2018)
Assessment of the correlations of lacosamide concentrations in saliva and serum in patients with epilepsy
Christian Brandt et al.
EPILEPSIA (2018)
LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting
Amaia Munoz-Lopetegi et al.
EPILEPSY RESEARCH (2018)
A case series of lacosamide as adjunctive therapy in refractory sleep-related hypermotor epilepsy (previously nocturnal frontal lobe epilepsy)
Shanika R. Samarasekera et al.
JOURNAL OF SLEEP RESEARCH (2018)
A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy
Gabriele Ruffolo et al.
NEUROBIOLOGY OF DISEASE (2018)
Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies
E. A. van Vliet et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2018)
Therapeutic Drug Monitoring of Antiepileptic Drugs in Epilepsy: A 2018 Update
Philip N. Patsalos et al.
THERAPEUTIC DRUG MONITORING (2018)
Reference ranges for antiepileptic drugs revisited: a practical approach to establish national guidelines
Arne Reimers et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Pregabalin and lacosamide ameliorate paclitaxel-induced peripheral neuropathy via inhibition of JAK/STAT signaling pathway and Notch-1 receptor
Khaled F. Al-Massri et al.
NEUROCHEMISTRY INTERNATIONAL (2018)
Lacosamide modulates collapsin response mediator protein 2 and inhibits mossy fiber sprouting after kainic acid-induced status epilepticus
Xue Wang et al.
NEUROREPORT (2018)
Influence of Dose and Antiepileptic Comedication on Lacosamide Serum Concentrations in Patients With Epilepsy of Different Ages
Theodor W. May et al.
THERAPEUTIC DRUG MONITORING (2018)
Individualized Dosing Algorithms and Therapeutic Monitoring for Antiepileptic Drugs
Sven C. van Dijkman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)
A review of medication adherence in people with epilepsy
N. Malek et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Discrepancies between physicians' prescriptions and patients' use of antiepileptic drugs
M. Mevaag et al.
ACTA NEUROLOGICA SCANDINAVICA (2017)
Lacosamide in status epilepticus: Systematic review of current evidence
Adam Strzelczyk et al.
EPILEPSIA (2017)
Pharmacokinetic drug evaluation of lacosamide for the treatment of partial-onset seizures
Stefano de Biase et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)
Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States
Sooyeon Jo et al.
MOLECULAR PHARMACOLOGY (2017)
Therapeutic Drug Monitoring of Lacosamide in Norway: Focus on Pharmacokinetic Variability, Efficacy and Tolerability
Torleiv Svendsen et al.
NEUROCHEMICAL RESEARCH (2017)
Lacosamide during pregnancy and breastfeeding
Simona Lattanzi et al.
NEUROLOGIA I NEUROCHIRURGIA POLSKA (2017)
Lacosamide Lowers Valproate and Levetiracetam Levels
Maria Tountopoulou et al.
NEUROPEDIATRICS (2017)
Mossy Fiber Sprouting in the Epileptic Brain: Taking on the Lernaean Hydra
Steve Danzer
EPILEPSY CURRENTS (2017)
(S)-Lacosamide Binding to Collapsin Response Mediator Protein 2 (CRMP2) Regulates CaV2.2 Activity by Subverting Its Phosphorylation by Cdk5
Aubin Moutal et al.
MOLECULAR NEUROBIOLOGY (2016)
Involvement of microRNAs in epileptogenesis
Adriano A. Cattani et al.
EPILEPSIA (2016)
Lacosamide tolerability in adult patients with partial-onset seizures: Impact of planned reduction and mechanism of action of concomitant antiepileptic drugs
Nancy Foldvary-Schaefer et al.
EPILEPSY & BEHAVIOR (2016)
Efficacy and safety of adjunctive lacosamide for the treatment of partial-onset seizures in Chinese and Japanese adults: A randomized, double-blind, placebo-controlled study
Zhen Hong et al.
EPILEPSY RESEARCH (2016)
Advances in the development of biomarkers for epilepsy
Asla Pitkanen et al.
LANCET NEUROLOGY (2016)
The challenges of treating epilepsy with 25 antiepileptic drugs
Lia Santulli et al.
PHARMACOLOGICAL RESEARCH (2016)
Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study
Bianca T. A. de Greef et al.
TRIALS (2016)
Molecular biomarkers in drug-resistant epilepsy: Facts & possibilities
Aparna Banerjee Dixit et al.
INTERNATIONAL JOURNAL OF SURGERY (2016)
Effect of Age and Sex on Lacosamide Pharmacokinetics in Healthy Adult Subjects and Adults with Focal Epilepsy
Carina Schaefer et al.
CLINICAL DRUG INVESTIGATION (2015)
Comparison of lacosamide concentrations in cerebrospinal fluid and serum in patients with epilepsy
Theodor W. May et al.
EPILEPSIA (2015)
Acute or chronic use of lacosamide does not alter its distribution between serum and cerebrospinal fluid
Sharon K. Michelhaugh et al.
EPILEPSIA (2015)
Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: Analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials
Victor Biton et al.
EPILEPSY & BEHAVIOR (2015)
Current understanding of the mechanism of action of the antiepileptic drug lacosamide
Michael A. Rogawski et al.
EPILEPSY RESEARCH (2015)
Demonstration of ameliorative effect of lacosamide: in a rat model of sepsis-induced critical illness polyneuropathy
Volkan Solmaz et al.
NEUROLOGICAL RESEARCH (2015)
Current Evidence-Based Paradigms for Diagnosis and Treatment
Kimberly Bates
PRIMARY CARE (2015)
Early pregnancy cerebral venous thrombosis and status epilepticus treated with levetiracetam and lacosamide throughout pregnancy
Pauli Ylikotila et al.
REPRODUCTIVE TOXICOLOGY (2015)
Seizures and Epilepsy: An Overview for Neuroscientists
Carl E. Stafstrom et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2015)
Specific Binding of Lacosamide to Collapsin Response Mediator Protein 2 (CRMP2) and Direct Impairment of its Canonical Function: Implications for the Therapeutic Potential of Lacosamide
Sarah M. Wilson et al.
MOLECULAR NEUROBIOLOGY (2015)
Advances in epilepsy treatment: lacosamide pharmacokinetic profile
Willi Cawello et al.
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALISTS FOR THE PRIX GALIEN USA AWARDS 2013 (2014)
Effect of Lacosamide on the Steady-State Pharmacokinetics of Digoxin: Results from a Phase I, Multiple-Dose, Double-Blind, Randomised, Placebo-Controlled, Crossover Trial
Willi Cawello et al.
CLINICAL DRUG INVESTIGATION (2014)
Pharmacokinetics of Lacosamide and Omeprazole Coadministration in Healthy Volunteers: Results from a Phase I, Randomized, Crossover Trial
Willi Cawello et al.
CLINICAL DRUG INVESTIGATION (2014)
Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study
Mercedes Garces et al.
EPILEPSY & BEHAVIOR (2014)
Past and Present Definitions of Epileptogenesis and Its Biomarkers
Asla Pitkanen et al.
NEUROTHERAPEUTICS (2014)
Lacosamide Serum Concentrations in Adult Patients With Epilepsy: The Influence of Gender, Age, Dose, and Concomitant Antiepileptic Drugs
Sofia Markoula et al.
THERAPEUTIC DRUG MONITORING (2014)
Antinociceptive effects of lacosamide on spinal neuronal and behavioural measures of pain in a rat model of osteoarthritis
Wahida Rahman et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Impact of Impaired Renal Function on the Pharmacokinetics of the Antiepileptic Drug Lacosamide
Willi Cawello et al.
CLINICAL PHARMACOKINETICS (2013)
Tolerability, pharmacokinetics, and bioequivalence of the tablet and syrup formulations of lacosamide in plasma, saliva, and urine: Saliva as a surrogate of pharmacokinetics in the central compartment
Willi Cawello et al.
EPILEPSIA (2013)
The adverse event profile of lacosamide: A systematic review and meta-analysis of randomized controlled trials
Gaetano Zaccara et al.
EPILEPSIA (2013)
Lack of effect of lacosamide on the pharmacokinetic and pharmacodynamic profiles of warfarin
Armel Stockis et al.
EPILEPSIA (2013)
Pharmacodynamic and pharmacokinetic evaluation of coadministration of lacosamide and an oral contraceptive (levonorgestrel plus ethinylestradiol) in healthy female volunteers
Willi Cawello et al.
EPILEPSIA (2013)
Lacosamide treatment following status epilepticus attenuates neuronal cell loss and alterations in hippocampal neurogenesis in a rat electrical status epilepticus model
Thomas Licko et al.
EPILEPSIA (2013)
Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation
Isabelle Niespodziany et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2013)
Valproic acid pathway: pharmacokinetics and pharmacodynamics
Yogita Ghodke-Puranik et al.
PHARMACOGENETICS AND GENOMICS (2013)
Intravenous lacosamide as treatment option in post-stroke non convulsive status epilepticus in the elderly: A proof-of-concept, observational study
Vincenzo Belcastro et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2013)
Efficacy of intravenous lacosamide as an add-on treatment in refractory status epilepticus: A multicentric prospective study
J. Miro et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2013)
Lacosamide Therapeutic Monitoring in Patients With Epilepsy: Effect of Concomitant Antiepileptic Drugs
Manuela Contin et al.
THERAPEUTIC DRUG MONITORING (2013)
Minimizing pharmacodynamic interactions of high doses of lacosamide
H. B. Edwards et al.
ACTA NEUROLOGICA SCANDINAVICA (2012)
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation
Steven Petratos et al.
BRAIN (2012)
Drug Binding Assays do not Reveal Specific Binding of Lacosamide to Collapsin Response Mediator Protein 2 (CRMP-2)
Christian Wolff et al.
CNS NEUROSCIENCE & THERAPEUTICS (2012)
Absorption, disposition, metabolic fate and elimination of the anti-epileptic drug lacosamide in humans: mass balance following intravenous and oral administration
Willi Cawello et al.
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS (2012)
Mechanisms of neuropathic pain
Florian T. Nickel et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
The use of newer antiepileptic drugs in patients with renal failure
Anyzeila Diaz et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2012)
No Pharmacokinetic Interaction Between Lacosamide and Valproic Acid in Healthy Volunteers
Willi Cawello et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Patterns of treatment response in newly diagnosed epilepsy
M. J. Brodie et al.
NEUROLOGY (2012)
Bioequivalence of Intravenous and Oral Formulations of the Antiepileptic Drug Lacosamide
Willi Cawello et al.
PHARMACOLOGY (2012)
Pharmacokinetics of Lacosamide in Healthy Korean Male Volunteers
Sung Eun Kim et al.
PHARMACOLOGY (2012)
Therapeutic Drug Monitoring of Lacosamide
Daniele Bentue-Ferrer et al.
THERAPIE (2012)
Adjunctive lacosamide in clinical practice: Sodium blockade with a difference?
Linda J. Stephen et al.
EPILEPSY & BEHAVIOR (2011)
Fluctuation of lacosamide serum concentrations during the day and occurrence of adverse drug reactions - First clinical experience
Annika Sattler et al.
EPILEPSY RESEARCH (2011)
Efficacy and Safety of Lacosamide in Painful Diabetic Neuropathy
Dan Ziegler et al.
DIABETES CARE (2010)
No Pharmacokinetic Interaction Between Lacosamide and Carbamazepine in Healthy Volunteers
Willi Cawello et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Pain perception is altered by a nucleotide polymorphism in SCN9A
Frank Reimann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Efficacy and Safety of Lacosamide in Diabetic Neuropathic Pain An 18-week Double-blind Placebo-controlled Trial of Fixed-dose Regimens
James P. Wymer et al.
CLINICAL JOURNAL OF PAIN (2009)
Long-term oral lacosamide in painful diabetic neuropathy: A two-year open-label extension trial
Aziz Shaibani et al.
EUROPEAN JOURNAL OF PAIN (2009)
Clinically relevant drug interactions with antiepileptic drugs
E Perucca
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Share Paper
